EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study

Josep Puig iD, Guillem Dolz, Mariano Werner, Pepus Daunis-I-Estadella iD, Marc Comas-Cufí, Alejandro Tomasello, Eva González, Xabier Manso Del Caño, Pedro Vega, Eduardo Murias, Isabel Bravo, Elvira Jiménez und 20 weitere

Journal of Neuroimaging · 2025

DOI: 10.1111/jon.70111 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuroimaging, 2025. Verfasst von Josep Puig und 31 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department CDI, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain. Hauptthemen laut MEDLINE: Thrombectomy, Stents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: iVascular.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Guidelines recommend stent retrievers (SRs) for treating large vessel occlusion (LVO) stroke. We assessed noninferiority of the iNtercept (iVascular) SR with a self‐expanding basket on a pusher wire versus contemporary SRs (CSRs) using propensity score (PS) matching analysis.

Methods

We analyzed data from the ROSSETTI multicenter registry of patients with anterior circulation LVO to compare procedural (recanalization rates according to the modified Thrombolysis In Cerebral Infarction (mTICI) score and procedural complications), clinical (modified Rankin Scale at 90 days), and safety (symptomatic intracranial hemorrhage, mortality at 90 days) outcomes of patients treated with iNtercept or CSRs (Solitaire, Trevo, and EmboTrap) as a first‐line strategy, with or without balloon‐guide catheter (BGC + SR, BCG − SR) after PS matching. Non‐inferiority of iNtercept was established if the prespecified lower bound of the 95% confidence interval was over −10%.

Results

A total of 164 and 132 patients treated first‐line by iNtercept were matched to 656 and 132 patients treated first‐line by CSR + BGC and CSR − BGC, respectively. After matching, successful reperfusion (mTICI2b/3) after first‐line strategy was achieved in 53.7% and 54.8% in the iNtercept versus CSR + BGC groups, respectively (absolute difference, −0.1%), and 53.8% and 51.3% in the iNtercept versus CSR − BGC, respectively (2.6%). Final reperfusion rates and favorable 90‐day outcomes were similar. iNtercept had fewer sICH, procedural complications, and emboli in a new territory than CSR + BGC, and fewer procedural complications than CSR − BGC.

Conclusions

This multicenter registry with PS matching demonstrated the non‐inferiority of iNtercept to approved CSRs for successful reperfusion in LVO acute ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombectomyStentsHumansFemaleMaleAgedRegistriesTreatment OutcomeMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

devicesmechanical thrombectomyoutcomestent retrieverstroke

Autor:innen und Institutionen

  • Radiology Department CDI, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain.
  • Neurointerventional Department CDI, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Department of Computer Science, Applied Mathematics and Statistics, University of Girona, Girona, Spain.
  • Interventional Neuroradiology, Vall D'hebron University Hospital, Barcelona, Spain.
  • Interventional Neuroradiology, Radiology, Hospital Cruces, Bilbao, Spain.
  • Radiology, Hospital Universitario Central De Asturias, Oviedo, Asturias, Spain.

ORCID-Profile: Josep Puig, Pepus Daunis-I-Estadella, Óscar Chirife

Förderung

  • iVascular

Zitieren

APA

Puig, J., Dolz, G., Werner, M., Daunis-I-Estadella, P., Comas-Cufí, M., Tomasello, A., González, E., Manso Del Caño, X., Vega, P., Murias, E., Bravo, I., Jiménez, E., Aparici-Robles, F., Sanchís, J. M., Remollo, S., Castaño, C., Moreu, M., López-Frías, A., Terceño, M., …, & ROSSETTI Group (2025). New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study. Journal of Neuroimaging. https://doi.org/10.1111/jon.70111

Vancouver

Puig J, Dolz G, Werner M, Daunis-I-Estadella P, Comas-Cufí M, Tomasello A, et al. New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study. Journal of Neuroimaging. 2025. doi:10.1111/jon.70111

BibTeX
@article{Puig2025,
  author = {Puig, Josep and Dolz, Guillem and Werner, Mariano and Daunis-I-Estadella, Pepus and Comas-Cufí, Marc and Tomasello, Alejandro and González, Eva and Manso Del Caño, Xabier and Vega, Pedro and Murias, Eduardo and Bravo, Isabel and Jiménez, Elvira and Aparici-Robles, Fernando and Sanchís, Juan Manuel and Remollo, Sebastià and Castaño, Carlos and Moreu, Manuel and López-Frías, Alfonso and Terceño, Mikel and Silva, Yolanda and Chirife, Óscar and López-Rueda, Antonio and Martínez-Fernández, Javier and Méndez, José Carlos and Sagredo, Antonio and Díaz-Pérez, José and Cuba, Víctor and Llibre, José Carlos and Aguilar, Yeray and SanRoman, Luis and Blasco, Jordi and ROSSETTI Group, ROSSETTI Group},
  title = {New Stent Retriever Technology Versus Standard Devices for Anterior Large Vessel Thrombectomy: A Multicenter Study},
  journal = {Journal of Neuroimaging},
  year = {2025},
  doi = {10.1111/jon.70111}
}
Kostenlos starten →